MedTrace Logo

Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

NCT01617772 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2018-05-11

No results posted yet for this study

Summary

The aim of the present study was to compare the effects of simvastatin and L-carnitine coadministration versus simvastatin, L-Carnitine monotherapy on liver transaminases and liver elasticity in NASH patients.

Conditions

  • Non-alcoholic Steatohepatitis

Interventions

DRUG

Atorvastatin

Atorvastatin 20 mg

DRUG

L-Carnitine

1000mg L-carnitine

DRUG

Placebo

Identically looking placebo

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Reza Malekzadeh, MD · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2019-10-31
Completion
2019-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01617772 on ClinicalTrials.gov